Carisma Therapeutics Inc.
CARMDelisted Dec 15, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001485003
Carisma Therapeutics Inc. was delisted on Dec 15, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 33 institutions reported holding it in 13F filings for Q3 2025, worth $842.6K in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Carisma Therapeutics Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 103 | 1 | 93 | −9 |
| Shares | 50.4M | 393.2K | 48.5M | −1.56M (−3.1%) |
| Value | $44.5M | $311.0K | $39.1M | −$5.07M (−11.5%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held Carisma Therapeutics Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Blodgett Wealth Advisors, LLC | 327,900 | $267.0K | 0.21% |
| Bridgeway Capital Management, LLC | 250,000 | $204.0K | 0.00% |
| Virtu Financial LLC | 191,192 | $156.0K | 0.02% |
| AQR Capital Management LLC | 190,443 | $155.0K | 0.00% |
| Engineers Gate Manager LP | 52,900 | $43.0K | 0.00% |
| Manufacturers Life Insurance Company, The | 26,588 | $22.0K | 0.00% |
| Mercer Global Advisors Inc | 22,200 | $18.0K | 0.00% |
| Personal Cfo Solutions, LLC | 18,000 | $15.0K | 0.00% |
| XTX Topco Ltd | 17,683 | $14.0K | 0.01% |
| Investment Advisory Group, LLC | 20,000 | $14.0K | 0.01% |
| Jacobs Levy Equity Management, Inc | 11,536 | $9.00K | 0.00% |
| Capital Performance Advisors LLP | 10,000 | $7.00K | 0.00% |
| Belvedere Trading LLC | 8,928 | $6.00K | 0.00% |
| National Bank of Canada | 2,220 | $2.00K | 0.00% |
| Castle Financial & Retirement Planning Associates, Inc. | 1,170 | $1.00K | 0.00% |
| TCI Wealth Advisors, Inc. | 600 | $0 | 0.00% |
| Retirement Planning Co of New England, Inc. | 50 | $0 | 0.00% |
| Zullo Investment Group, Inc. | 150 | $0 | 0.00% |
Sold out (27)
Institutions that held Carisma Therapeutics Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
Not filed for Q4 2021 yet (1)
Institutions that held Carisma Therapeutics Inc. at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Marshall Wace North America L.P. | 393,216 | $311.0K |